1,036
Participants
Start Date
September 30, 2009
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
exenatide
subcutaneous injection, 5mcg (4 weeks) followed by 10mcg (26 weeks), twice a day
insulin lispro
titrated based on pre-meal glucose level; three times a day
Metformin
Insulin/ Glargine
Research Site, Buenos Aires
Research Site, Caba
Research Site, Capital Federal
Research Site, Ciudad Autonoma de Buenos Aire
Research Site, Ciudad de Buenos Aires
Research Site, Corrientes
Research Site, Rosario
Research Site, San Rafael
Research Site, Arlon
Research Site, Bonheiden
Research Site, Edegem
Research Site, Merksem
Research Site, Tallinn
Research Site, Tartu
Research Site, Helsinki
Research Site, Oulu
Research Site, Vantaa
Research Site, Angers
Research Site, Auxerre
Research Site, Bar-le-Duc
Research Site, Douai
Research Site, La Roche-sur-Yon
Research Site, La Rochelle
Research Site, Le Creuzot
Research Site, Lille
Research Site, Marseille
Research Site, Montpellier
Research Site, Nanterre
Research Site, Pessac
Research Site, Rennes
Research Site, Strasbourg
Research Site, Toulouse
Research Site, Vénissieux
Research Site, Bad Lauterberg im Harz
Research Site, Dippoldiswalde
Research Site, Friedrichsthal
Research Site, Goch
Research Site, Grevenbroich
Research Site, Hamburg
Research Site, Mainz
Research Site, Saarbrücken
Research Site, Athens
Research Site, Thessaloniki
Research Site, Florence
Research Site, Napoli
Research Site, Olbia
Research Site, Perugia
Research Site, Trieste
Research Site, Verona
Research Site, Aguascalientes
Research Site, Cuernavaca
Research Site, Mexico City
Research Site, Monterrey
Research Site, Almere Stad
Research Site, Amsterdam
Research Site, Beek
Research Site, Groningen
Research Site, Heerlen
Research Site, Hoogeveen
Research Site, Sittard-Geleen
Research Site, The Hague
Research Site, Coimbra
Research Site, Lisbon
Research Site, Portugal
Research Site, Hato Rey
Research Site, Bucharest
Research Site, Cluj-Napoca
Research Site, Constanța
Research Site, Craiova
Research Site, Oradea
Research Site, Ploieşti
Research Site, Arkhangelsk
Research Site, Rostov-on-Don
Research Site, Saint Petersburg
Research Site, Seoul
Research Site, Ulsan
Research Site, Wŏnju
Research Site, A Coruña
Research Site, Alicante
Research Site, Barcelona
Research Site, Dos Hermanas
Research Site, Santander
Research Site, Valencia
Research Site, Halmstad
Research Site, Karlstad
Research Site, Lund
Research Site, Malmo
Research Site, Solna
Research Site, Stockholm
Research Site, Umeå
Research Site, Bournemouth
Research Site, Ipswich
Research Site, Leicester
Research Site, Penarth
Research Site, Wakefield
Lead Sponsor
Eli Lilly and Company
INDUSTRY
AstraZeneca
INDUSTRY